Amir Valizadeh
Associate Research ScientistCards
Contact Info
Xu Lab
National Center for PTSD, Orange VA Clinic, 200 Edison Rd
Orange, CT 06477
United States
Publications Overview
- 14 Publications
- 353 Citations
- 10 Yale Co-Authors
About
Copy Link
Titles
Associate Research Scientist
Biography
Amir Valizadeh earned his MD from Tehran University of Medical Sciences in 2019. His research integrates computational biology, machine learning, and clinical expertise, with a focus on multi-omics integration, epigenomic profiling, and biomarker discovery in psychiatry and immunology. Currently, as a Postdoctoral Associate at Yale School of Medicine and VA Connecticut Healthcare System, he is exploring transcriptomic alterations in SIV/HIV infection and leveraging AI for precision diagnostics, such as DNA methylation-based prediction of ketamine response in PTSD.
Appointments
Psychiatry
Associate Research ScientistPrimary
Other Departments & Organizations
Education & Training
- Postdoctoral Associate
- Yale University (2025)
- Postdoctoral Research Fellow
- Tehran University Of Medical Sciences (2022)
- Research Assistant
- Research Center for Molecular and Cellular Imaging (2020)
- MD
- Tehran University Of Medical Sciences, Medicine (2019)
- Student Researcher
- Research Center for Immunodeficiencies (2018)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0001-5983-8527- View Lab Website
Xu Lab
Research at a Glance
Yale Co-Authors
Publications Timeline
Ke Xu, MD
Chadi Abdallah, MD
Ismene Petrakis, MD
John Krystal, MD
Lynnette A. Averill, PhD
Matthew Girgenti, PhD
Publications
2025
Combining DNA methylation features and clinical characteristics predicts ketamine treatment response for PTSD
Valizadeh A, Roache J, Zhang X, Hu Y, Gueorguieva R, Averill L, Ranganathan M, Wang Z, Williamson D, Shiroma P, Girgenti M, Petrakis I, López-Roca A, Young-McCaughan S, Keane T, Peterson A, Abdallah C, Krystal J, Xu K, PTSD F. Combining DNA methylation features and clinical characteristics predicts ketamine treatment response for PTSD. IScience 2025, 29: 114445. PMID: 41561376, PMCID: PMC12814687, DOI: 10.1016/j.isci.2025.114445.Peer-Reviewed Original ResearchCitationsAltmetricInfections in patients with multiple sclerosis treated with disease-modifying therapies: A comparative risk assessment cohort study
Fattahi M, Valizadeh A, Azimi A, Moghadasi A, Ghasemi M, Navardi S, Doosti R, Hemmati Z, Zare-Dehnavi A, Iranmehr A, Hamtaei-Gashti S, Sahraian M. Infections in patients with multiple sclerosis treated with disease-modifying therapies: A comparative risk assessment cohort study. Iranian Journal Of Neurology 2025, 24: 115-126. PMID: 42158302, PMCID: PMC13183252, DOI: 10.18502/cjn.v24i2.20684.Peer-Reviewed Original ResearchTranscriptomic Alterations Induced by Tetrahydrocannabinol in SIV/HIV Infection: A Systematic Review
Valizadeh A, Veenhuis R, Bradley B, Xu K. Transcriptomic Alterations Induced by Tetrahydrocannabinol in SIV/HIV Infection: A Systematic Review. International Journal Of Molecular Sciences 2025, 26: 2598. PMID: 40141240, PMCID: PMC11942185, DOI: 10.3390/ijms26062598.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAberrant DNA methylation of genes regulating CD4+ T cell HIV‐1 reservoir in women with HIV
Xu K, Zhang X, Asam K, Quach B, Page G, Konkle‐Parker D, Martinez C, Lahiri C, Topper E, Cohen M, Kassaye S, DeHovitz J, Kuniholm M, Archin N, Valizadeh A, Tien P, Marconi V, Hancock D, Johnson E, Aouizerat B. Aberrant DNA methylation of genes regulating CD4+ T cell HIV‐1 reservoir in women with HIV. Clinical And Translational Medicine 2025, 15: e70267. PMID: 40070009, PMCID: PMC11896887, DOI: 10.1002/ctm2.70267.Peer-Reviewed Original ResearchCitations
2023
Automated diagnosis of autism with artificial intelligence: State of the art
Valizadeh A, Moassefi M, Nakhostin-Ansari A, Some’eh S, Hosseini-Asl H, Torbati M, Aghajani R, Ghorbani Z, Menbari-Oskouie I, Aghajani F, Mirzamohamadi A, Ghafouri M, Faghani S, Memari A. Automated diagnosis of autism with artificial intelligence: State of the art. Reviews In The Neurosciences 2023, 35: 141-163. PMID: 37678819, DOI: 10.1515/revneuro-2023-0050.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitations
2022
The mirror mechanism in schizophrenia: A systematic review and qualitative meta-analysis
Valizadeh A, Mbwogge M, Yazdi A, Amlashi N, Haadi A, Shayestefar M, Moassefi M. The mirror mechanism in schizophrenia: A systematic review and qualitative meta-analysis. Frontiers In Psychiatry 2022, 13: 884828. PMID: 36213922, PMCID: PMC9532849, DOI: 10.3389/fpsyt.2022.884828.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricAbstract screening using the automated tool Rayyan: results of effectiveness in three diagnostic test accuracy systematic reviews
Valizadeh A, Moassefi M, Nakhostin-Ansari A, Hosseini Asl S, Saghab Torbati M, Aghajani R, Maleki Ghorbani Z, Faghani S. Abstract screening using the automated tool Rayyan: results of effectiveness in three diagnostic test accuracy systematic reviews. BMC Medical Research Methodology 2022, 22: 160. PMID: 35655155, PMCID: PMC9161508, DOI: 10.1186/s12874-022-01631-8.Peer-Reviewed Original ResearchCitationsAltmetricThe safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial
Zarrabi M, Akbari M, Amanat M, Majmaa A, Moaiedi A, Montazerlotfelahi H, Nouri M, Hamidieh A, Badv R, Karimi H, Rabbani A, Mohebbi A, Rahimi-Dehgolan S, Rahimi R, Dehghan E, Vosough M, Abroun S, Shamsabadi F, Tavasoli A, Alizadeh H, Pak N, Zamani G, Mohammadi M, Javadzadeh M, Ghofrani M, Hassanpour S, Heidari M, Taghdiri M, Mohseni M, Noparast Z, Masoomi S, Goudarzi M, Mohamadpour M, Shodjaee R, Samimi S, Mohammad M, Gholami M, Vafaei N, Koochakzadeh L, Valizadeh A, Malamiri R, Ashrafi M. The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial. BMC Neurology 2022, 22: 123. PMID: 35351020, PMCID: PMC8966246, DOI: 10.1186/s12883-022-02636-y.Peer-Reviewed Original ResearchCitationsAltmetricDisease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis
Valizadeh A, Fattahi M, Sadeghi M, Torbati M, Sahraian M, Azimi A. Disease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis. CNS Neuroscience & Therapeutics 2022, 28: 648-657. PMID: 35218155, PMCID: PMC8981477, DOI: 10.1111/cns.13815.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
2021
Correlation between the clinical disability and T1 hypointense lesions’ volume in cerebral magnetic resonance imaging of multiple sclerosis patients: A systematic review and meta‐analysis
Valizadeh A, Moassefi M, Barati E, Sahraian M, Aghajani F, Fattahi M. Correlation between the clinical disability and T1 hypointense lesions’ volume in cerebral magnetic resonance imaging of multiple sclerosis patients: A systematic review and meta‐analysis. CNS Neuroscience & Therapeutics 2021, 27: 1268-1280. PMID: 34605190, PMCID: PMC8504532, DOI: 10.1111/cns.13734.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
Academic Achievements & Community Involvement
Copy Link
Activities
activity Student Headquarters Against COVID-19 at Tehran University of Medical Sciences
2020 - 2020Public ServiceVice Presidentactivity Internship Committee at Tehran University of Medical Sciences
2019 - 2020CommitteesChair
News & Links
Copy Link
Get In Touch
Copy Link
Contacts
Xu Lab
National Center for PTSD, Orange VA Clinic, 200 Edison Rd
Orange, CT 06477
United States
Xu Lab
Department of Biomedical Informatics & Data Science, 101 College St, Fl 10
New Haven, CT 06510
United States
Social Media